Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.

Matejko B, Cyganek K, Katra B, Galicka-Latala D, Grzanka M, Malecki MT, Klupa T.

Rev Diabet Stud. 2011 Summer;8(2):254-8. doi: 10.1900/RDS.2011.8.254. Epub 2011 Aug 10.

PMID:
22189548
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?

Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M.

Diabetes Technol Ther. 2012 May;14(5):389-97. doi: 10.1089/dia.2011.0267. Epub 2012 Jan 27.

PMID:
22283639
[PubMed - indexed for MEDLINE]
3.

Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.

Zucchini S, Scipione M, Balsamo C, Maltoni G, Rollo A, Molinari E, Mangoni L, Cicognani A.

Diabetes Technol Ther. 2011 Dec;13(12):1187-93. doi: 10.1089/dia.2011.0080. Epub 2011 Aug 19.

PMID:
21854193
[PubMed - indexed for MEDLINE]
5.

A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.

Abaci A, Atas A, Unuvar T, Demir K, Bober E, Büyükgebiz A.

J Pediatr Endocrinol Metab. 2009 Jun;22(6):539-45.

PMID:
19694201
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of insulin pump treatment in adult T1DM patients--influence of age and social environment.

Grzanka M, Matejko B, Cyganek K, Kozek E, Małecki MT, Klupa T.

Ann Agric Environ Med. 2012;19(3):573-5.

PMID:
23020059
[PubMed - indexed for MEDLINE]
Free Article
7.

Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII.

Anderson DG.

Pediatr Diabetes. 2009 Aug;10(5):304-9. doi: 10.1111/j.1399-5448.2008.00484.x. Epub 2008 Dec 5.

PMID:
19076301
[PubMed - indexed for MEDLINE]
8.

[Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].

Hasselmann C, Bonnemaison E, Faure N, Mercat I, Bouillo Pépin-Donat M, Magontier N, Chantepie A, Labarthe F.

Arch Pediatr. 2012 Jun;19(6):593-8. doi: 10.1016/j.arcped.2012.03.051. Epub 2012 May 14. French.

PMID:
22584198
[PubMed - indexed for MEDLINE]
9.

Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden.

Carlsson BM, Attvall S, Clements M, Gumpeny SR, Pivodic A, Sternemalm L, Lind M.

Diabetes Technol Ther. 2013 Apr;15(4):302-7. doi: 10.1089/dia.2012.0286. Epub 2013 Mar 28.

PMID:
23537418
[PubMed - indexed for MEDLINE]
10.

Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

Diabetes Technol Ther. 2005 Aug;7(4):587-96.

PMID:
16120030
[PubMed - indexed for MEDLINE]
11.

Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.

Cohen ND, Hong ES, Van Drie C, Balkau B, Shaw J.

Diabetes Technol Ther. 2013 Jul;15(7):544-9. doi: 10.1089/dia.2012.0331. Epub 2013 Apr 25.

PMID:
23617252
[PubMed - indexed for MEDLINE]
12.

Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.

Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL.

Diabetes Technol Ther. 2011 Oct;13(10):1023-30. doi: 10.1089/dia.2011.0085. Epub 2011 Jun 30.

PMID:
21718094
[PubMed - indexed for MEDLINE]
13.

Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients.

Yardley JE, Iscoe KE, Sigal RJ, Kenny GP, Perkins BA, Riddell MC.

Diabetes Technol Ther. 2013 Jan;15(1):84-8. doi: 10.1089/dia.2012.0168. Epub 2012 Dec 6.

PMID:
23216304
[PubMed - indexed for MEDLINE]
14.
15.

Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.

Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB.

Diabetes Technol Ther. 2012 Jul;14(7):644-7. doi: 10.1089/dia.2011.0294. Epub 2012 Apr 23.

PMID:
22524549
[PubMed - indexed for MEDLINE]
16.
17.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
[PubMed - indexed for MEDLINE]
18.

Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.

Catargi B, Meyer L, Melki V, Renard E, Jeandidier N; EVADIAC Study Group.

Diabetes Metab. 2002 Apr;28(2):133-7.

PMID:
11976565
[PubMed - indexed for MEDLINE]
Free Article
19.

Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.

Rodbard D, Jovanovic L, Garg SK.

Diabetes Technol Ther. 2009 Dec;11(12):757-65. doi: 10.1089/dia.2009.0078.

PMID:
20001676
[PubMed - indexed for MEDLINE]
20.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk